Abstract
An ongoing monitoring program is an essential component of operating a Good Manufacturing Practice (GMP) facility. To support manufacture of clinical grade viral gene transfer vectors, the Belfer Gene Therapy Core Facility has a Class 100,000 GMP facility with three production laboratories, in which all open operations of production are conducted in Class 100 biological safety cabinets. The routine monitoring program measures viable and non-viable particles weekly and temporal trending is assessed to identify emerging problems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.